Pharma's two blind spots on AI labs' bid to cure disease, argued in viral thread
bookwormengr · x · 2026-11-14
purrmin argues pharma insiders are right to push back on Dario's bold curing-all-disease claims since key bio data doesn't exist yet — but they miss two blind spots: the industry has never faced a small, well-capitalized Silicon Valley team (no Instagram/WhatsApp/ARM/Cursor moment yet), and AI labs must win in bio to double TAM, with tech's liquidity riding on it. bookwormengr adds that Anthropic/OpenAI's AI-for-Science teams could still cure cancer and other diseases despite brutal regulation, slow trials, and high standards.
More from AGI Musings
- Interconnects: Jensen's resignation is a major setback for US open-model ecosystem — Interconnects (Nathan Lambert) · 2026-11-14
- AGI endgame: either a balanced multipolar world or a centralized panopticon — CedricMakes · 2026-11-14
- "60% of people around you have some form of AI psychosis," says Alsop III — StewartalsopIII · 2026-11-14
- AI won't make everyone equal—it will split the smart from the rest worse than money — prasenx · 2026-11-14
- Toddlers learn new verbs only from responsive partners; a call to rerun the test with AI — AnnaCiaunica · 2026-11-14
- Developer muses: in Murphy's world, billions of interdependent events make rare failures daily — bingxu_ · 2026-11-14